The Cancer Service Line (CSL) and the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) are delighted to announce the selection of the 2022 Access Accelerator project. 

The chosen project, submitted by Alfred Garfall, MD, in collaboration with Keith Pratz, MD and Noelle Frey, MD, MS, seeks to enhance outpatient care for advanced hematologic malignancies therapies. 

Over the next six months, this team will work closely with innovation and operational support from CSL and PC3I to design and test an intervention to improve patient access to hematologic oncology care. They will also receive mentorship and advising from a broad group of stakeholders representing both inpatient and outpatient hematologic care as well as health system operations and leadership. At the conclusion of the pilot, the project team will present its progress and findings and identify opportunities for scale.